SCHEMBL8736364

SCHEMBL8736364

CC[C@H]1CCC[C@H](O)C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17835258 1.00
SCHEMBL14474737 1.00
SCHEMBL2163319 1.00
SCHEMBL17835257 1.00
SCHEMBL8736366 1.00
SCHEMBL13392845 1.00
Hydrochloric Acid SCHEMBL27683920 0.98 CNR2 (0.35)
SCHEMBL4840204 0.95 TSHR (0.43)
SCHEMBL4840420 0.93 TSHR (0.41)
SCHEMBL16900558 0.92 TSHR (0.38)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0885318-A1 FLASH SPINNING PROCESS AND PRODUCTS E.I. DU PONT DE NEMOURS & COMPANY INCORPORATED (US) 1998-12-23 EP claimed
WO-1997033021-A1 FLASH SPINNING PROCESS AND PRODUCTS E.I. DU PONT DE NEMOURS AND COMPANY (US) 1997-09-12 WO claimed
US-11174245-B2 Benzimidazole compounds and derivatives as EGFR inhibitors BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2021-11-16 US disclosed
US-20200377476-A1 NEW BENZIMIDAZOLE COMPOUNDS AND DERIVATIVES AS EGFR INHIBITORS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2020-12-03 US disclosed
US-10570145-B2 TYK2 inhibitors and uses thereof Nimbus Lakshimi, Inc. (US) 2020-02-25 US disclosed
US-20190241577-A1 TYK2 INHIBITORS AND USES THEREOF TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2019-08-08 US disclosed
WO-2019023468-A1 TYK2 INHIBITORS AND USES THEREOF NIMBUS LAKSHMI, INC. (US) 2019-01-31 WO disclosed